Nasal allergies and beyond: a clinical review of the pharmacology, efficacy, and safety of mometasone furoate

被引：0

作者：

van Drunen, C

Meltzer, EO

Bachert, C

Bousquet, J

Fokkens, WJ

机构：

[1] Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, NL-1100 DD Amsterdam, Netherlands

[2] Allergy & Asthma Med Grp & Res Ctr, San Diego, CA USA

[3] Ghent Univ Hosp, ENT Dept, B-9000 Ghent, Belgium

[4] Cent Hosp Univ, Hop Arnaud de Villeneuve, Dept Resp Dis, Montpellier, France

来源：

ALLERGY | 2005年 / 60卷

关键词：

mometasone furoate; allergic rhinitis; nasal allergies; intranasal corticosteroids;

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Mometasone furoate nasal spray (MFNS; Nasonex(R), Schering-Plough Corporation, Kenilworth, NJ, USA) is an effective and well-tolerated intranasal corticosteroid approved for the prophylactic treatment of seasonal allergic rhinitis, and the treatment of perennial allergic rhinitis. MFNS is a potent molecule with a rapid onset of action and excellent safety and efficacy profiles. Having recently received approval for the treatment of nasal polyposis, data indicate that MFNS may also be effective in rhinosinusitis.

引用

页码：5 / 19

页数：15

共 83 条

[71] MECHANISMS, DIAGNOSIS, AND TREATMENT OF SINUSITIS IN CHILDREN AND ADULTS - INTRODUCTION AND DEFINITION OF SINUSITIS [J].